The high (I)COSt of costimulation for exhausted T cells
Immunity · 2025
DOI: 10.1016/j.immuni.2025.07.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, 2025. Verfasst von Maria N de Menezes und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Me…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Inducible T-Cell Co-Stimulator Protein, Neoplasms. Die Arbeit nennt 10 Literaturangaben. Gefördert von: Victorian Cancer Agency.
Abstract (Originalsprache)
ICOS agonists are being investigated for cancer immunotherapy based on the idea that they will reinvigorate exhausted CD8+ T cell anti-cancer immunity. Humblin et al. unexpectedly find the opposite-that CD8+ T cell-intrinsic ICOS expression restrains rather than promotes exhausted CD8+ T cell function in both chronic viral infection and tumor models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.
- Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. Electronic address: ian.parish@pet…
Förderung
- Victorian Cancer Agency
Zitieren
APA
de Menezes, M. N., & Parish, I. A. (2025). The high (I)COSt of costimulation for exhausted T cells. Immunity. https://doi.org/10.1016/j.immuni.2025.07.010
Vancouver
de Menezes MN, Parish IA. The high (I)COSt of costimulation for exhausted T cells. Immunity. 2025. doi:10.1016/j.immuni.2025.07.010
BibTeX
@article{deMenezes2025,
author = {de Menezes, Maria N and Parish, Ian A},
title = {The high (I)COSt of costimulation for exhausted T cells},
journal = {Immunity},
year = {2025},
doi = {10.1016/j.immuni.2025.07.010}
}
EUVIMED